Scala Biodesign launches with $5.5M to develop bioproducts from proteins
Tel Aviv-based AI-enabled computational protein engineering platform Scala Biodesign announced its launch today with $5.5 million in seed funding.The round was led by TLV Partners, an Israeli venture capital firm that invests in early-stage…
Continue Reading
